BioNexus Gene Lab Corp. Files 8-K

Ticker: BGLC · Form: 8-K · Filed: Mar 5, 2025 · CIK: 1737523

Bionexus Gene Lab CORP 8-K Filing Summary
FieldDetail
CompanyBionexus Gene Lab CORP (BGLC)
Form Type8-K
Filed DateMar 5, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, regulatory-filing

TL;DR

BioNexus Gene Lab Corp. filed a routine 8-K on March 5, 2025. No major news.

AI Summary

BioNexus Gene Lab Corp. filed an 8-K on March 5, 2025, reporting other events and financial statements. The company, incorporated in Wyoming, is based in Kuala Lumpur and operates in the medical laboratories sector. This filing does not appear to contain specific financial figures or significant operational updates beyond the standard reporting requirements.

Why It Matters

This 8-K filing indicates BioNexus Gene Lab Corp. is meeting its regulatory reporting obligations. Investors should review the full filing for any material information not summarized here.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report and does not contain information that suggests an immediate change in risk for the company.

Key Players & Entities

FAQ

What is the primary business of BioNexus Gene Lab Corp.?

BioNexus Gene Lab Corp. operates in the SERVICES-MEDICAL LABORATORIES sector, with SIC code 8071.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on March 5, 2025.

Where are BioNexus Gene Lab Corp.'s principal executive offices located?

The principal executive offices of BioNexus Gene Lab Corp. are located at Unit A-28-7, Tower A, Menara UOA Bangsar, No.5 Jln Bangsar Utama 1, 59000 Kuala Lumpur.

What is the company's IRS Employer Identification Number?

The IRS Employer Identification Number for BioNexus Gene Lab Corp. is 26-2124961.

What is the Commission File Number for BioNexus Gene Lab Corp.?

The Commission File Number for BioNexus Gene Lab Corp. is 001-41750.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 5, 2025 regarding BioNexus Gene Lab Corp (BGLC).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing